NUI
No nā nīnau e pili ana i kā mākou huahana a i ʻole ka papa inoa kumukūʻai, e ʻoluʻolu e waiho i kāu leka uila iā mākou a e hoʻopili mākou i loko o 24 mau hola.
NINAU ANOKūlana kaʻahele:
ʻO ka halihali kaulahao anu (-18 ℃~-22 ℃)
Manaʻo i ke ʻano hoʻouna
Ma ka lewa Ma ka aina Ma ke kai
ʻO ka halihali kaulahao anu (-18 ℃~-22 ℃)
Kūlana mālama:
E mālama i loko o ka pahu hau (-18 ~ -30 ℃)
E hoʻokomo iā lākou i loko o kahi maloʻo maloʻo, kahi waiho ʻeleʻele.
Ola ola:
Ma kahi o 6 mahina
(Inā ʻoi aku ma mua o ʻeono mahina, pono ʻoe e hoʻāʻo ma mua o ka hoʻohana ʻana e hōʻoia i ka maikaʻi.)
Ka nui o ke kauoha liʻiliʻi:
10gm (kūkākūkā)
palapala hōʻoia:COA, HPLC, GC, HNMR, Assay, Water Content(KF), TLC loaʻa
E hāʻawi mākou i nā ʻikepili āu e pono ai.
(S)-4-Methyloxazolidine-2,5-dioneL-Alanine N-Carbxy;
anhydrideZLE0086(4S)-4-Methyl-1,3-oxazolidine-2,5-dioneL-alanine;
N-carboxyanhydrideN-Carboxyalanine;
L-alanine anhydride2,5-Oxazolidinedione, 4-methyl-, (4S)-L-Ala-N-carboxyanhydride;
N-Carboxy-L-alanine anhydride
ʻEhā ʻokoʻa ka nui o nā ʻeke, e hoʻouka ana mai 1g a 10kg.Hana ʻia lākou me ka alumini foil hiki ke pale aku i nā huahana mai ka lā, ka wai a me ka ea.
Nui nā ʻano nui like ʻole o nā pahu paʻa i hiki ke hōʻoia i ka hōʻea ʻana o nā huahana i kahi wahi me ka palekana a piha.
2224-52-4 L-Ala-NCA hiki ke hoʻohana i ka 13485-59-1 L-Ala-Pro-OH, ʻo ia kekahi o nā mea waena o Enalapril.
Hiki iā ia ke hōʻemi maikaʻi i ka hoʻokuʻu ʻana o nā mea maʻi me ka protein urine, hoʻomaikaʻi i ka hana renal transplantation, hoʻopaneʻe i ka hoʻomohala ʻana o ka maʻi maʻi transplantation maʻi a me ka maʻi ʻāʻī me ke kōkua o Bailing a me Enalapril.ʻOi aku ka maikaʻi o ka hana o nā lāʻau ʻelua ma mua o kekahi o lākou.2) Hiki i ka Enalapril ke hoʻemi i ka fibrosis kidney ma o ka hoʻohaʻahaʻa ʻana i nā kumu ulu o ka ʻiʻo concentrated a mālama i nā maʻi maʻi ʻokoʻa.3) Hiki ke hoʻohana ʻia ʻo Enalapril a me Irbesartan e hoʻomaikaʻi i ke ʻano hou o ka aorta ma mua o nā lāʻau ʻelua.Hiki ke pili ka mīkini i ka hoʻonui ʻana i ka hana o ka pāpaʻi sodium aorta a me ka hana pāpaʻi calcium.Hiki i ka Enalapril ke hoʻomaikaʻi i ka hana o ka pauma sodium a me ka pauma calcium ma o ka hoʻoponopono ʻana i ka pāpaʻu sodium a me ka pauma calcium i ka pae hōʻike mRNA, kaohi ʻana i ka ʻāʻī vascular Ⅱ (ANGIOTENSIN Ⅱ, ANGI), e hoʻomaikaʻi i ka hoʻoponopono hou ʻana o ka arterial Central arterial compression and reflection wave booster index, hoʻohuli i ka hypertrophy o ʻo ka ventricular hema e hoʻokō me ka palekana a me ka hoʻomalu pono i ke koko.4) He kūpono a palekana hoʻi e hoʻohana i ka Enalapril a me Metoprolol Tartrate Tablets e mālama iā CHF.
ʻO 2224-52-4 L-Ala-NCA kekahi o nā mea waena o Glatiramer acetate.
ʻO Glatirameracetate kahi analogue synthetic o ka myelin basic protein a me kahi immunomodulator no ka hoʻohana ʻana i nā sclerosis lehulehu. Hōʻike ʻo Glatirameracetate i ka paʻa ikaika a me ka moe kolohe i nā mole MHC, no laila e hoʻokūkū nei me nā ʻano myelin antigens no ka hōʻike ʻana i nā cell T. ʻO kekahi ʻaoʻao ʻo ka hoʻokomo pono ʻana o T helper 2 (Th2)-specific suppressor cell to migrate to the brain and lead to in situ bystander suppression.
L-Lys(tfa)-NCA | Sar-NCA | L-Val-NCA |
Lys(Cbz)-NCA | Gly-NCA | L-Leu-NCA |
D-Lys(Cbz)-NCA | D-Leu-NCA | D-Glu(Obzl)-NCA |
L-Tyr-NCA | D-Ala-NCA | Ile-NCA |
D-Tyr-NCA | HL-Asp(OBzl)-NCA | HD-Asp(OBzl)-NCA |
L-Phe-NCA | Orn(Cbz)-NCA | L-Glu(Obzl)-NCA |
DL-Glu(Obzl)-NCA |
1. Hāʻawi mākou i ka hana maʻamau i nā huahana āu e pono ai.
2. Hiki ke hāʻawi ʻia ke kumukūʻai kiʻekiʻe & hoʻokūkū.
3.We hoʻohiki i kahi papa piha o ka lawelawe ukali no ʻoe.
4. Hiki ke hā'awi 'ia ka nīnau nīnau mea kū'ai a me nā palapala 'ike loea inā noi ma hope o ka hālāwai 'ana i kekahi huina.
5. Nui ma hope o ke kūʻai aku ʻana a i ʻole ka hōʻoia ʻana: E hoʻoponopono koke ʻia kāu nīnau i ka hiki.
6. E hoʻokuʻu aku i nā huahana hoʻokūkū a hoʻokuʻu aku iā lākou i waho i nā mea nui i kēlā me kēia makahiki.
7.Free hāpana hāʻawi ʻia e nānā i ka maikaʻi ma mua o kekahi uku.